Opciones de comparación: el sistema C
está diseñado para su uso con sangre total capilar y venosa.
Debe realizarse la comparación con un método de laboratorio
simultáneamente con alícuotas de la misma muestra.
NOTA: Las concentraciones de glucosa disminuyen rápidamente
debido a la glucólisis (aproximadamente 5 %–7 % por hora).
Referencias
1. Wickham NWR, et al. Unreliability of capillary blood glucose in
peripheral vascular disease. Practical Diabetes. 1986;3(2):100.
2. Atkin SH, et al. Fingerstick glucose determination in shock. Annals of
Internal Medicine. 1991;114(12):1020-1024.
3. Desachy A, et al. Accuracy of bedside glucometry in critically ill
patients: influence of clinical characteristics and perfusion index.
Mayo Clinic Proceedings. 2008;83(4):400-405.
70
90007655_CntrPlsELT_UG_b5714743_es-419_MX-ES_812323CMS.indd 70-71
P
ELITE
ontour
lus
7
4. American Diabetes Association. Standards of medical care in
diabetes—2016. Diabetes Care. 2016;39(supplement 1):S15.
5. US Food and Drug Administration. Use of fingerstick devices
on more than one person poses risk for transmitting bloodborne
pathogens: initial communication. US Department of Health and
Human Services; update 11/29/2010. http://wayback.archive-it.
org/7993/20170111013014/http://www.fda.gov/MedicalDevices/
Safety/AlertsandNotices/ucm224025.htm
6. Centers for Disease Control and Prevention. Infection Prevention
during Blood Glucose Monitoring and Insulin Administration. US
Department of Health and Human Services; update June 8, 2017.
http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html
7. Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical
Chemistry. 5th edition. Philadelphia, PA: WB Saunders Co; 2001;444.
Sistema para monitoreo de glucosa en sangre C
INFORMACIÓN TÉCNICA
71
P
ELITE
ontour
®
lus
3/1/22 1:21 PM